Search results
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
Benzinga via Yahoo Finance· 1 year agoRoche Group Holdings AG's (OTC: RHHBY) data from the global phase 3 COMMODORE 1 and 2 studies...
LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program
Benzinga via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (NASDAQ: LVTX) hosted a clinical update call focused on initial Phase 1/2a...
Why Shares of Omeros Dropped on Monday
Motley Fool· 1 year agoShares of Omeros (NASDAQ: OMER) were down 12.9% early Monday afternoon after the clinical-stage biopharmaceutical company released a presentation it made...
Why Bluebird Bio Skyrocketed Today
Motley Fool· 2 years agoShares of Bluebird Bio (NASDAQ: BLUE) had popped by more than 34.3% at 10:58 ET Friday morning amid a wider rally in the cell and gene therapy segments of the biotech industry. The jump in its ...
Roche (RHHBY) Announces Positive Results From PNH Studies
Zacks via Yahoo Finance· 1 year agoRoche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in...
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
Benzinga via Yahoo Finance· 2 months agoOn Monday, Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and...
Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma...
Benzinga via Yahoo Finance· 1 year agoSeagen Inc (NASDAQ: SGEN) announced updated efficacy and safety results from Part C of phase 2...
Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Call Transcript August 2, 2023 Editas Medicine,...
Q2 2023 Rigel Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants David A. Santos; Executive VP & Chief Commercial Officer; Rigel Pharmaceuticals, Inc. Dean L. Schorno; Executive VP & CFO; Rigel Pharmaceuticals, Inc. Raul R. Rodriguez; President ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoAllogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript November 2, 2023 Allogene...